Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas

Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas

Bibliographic Details
Main Authors:	Amandine Crombé, Mariella Spalato‐Ceruso, Audrey Michot, Yech'an Laizet, Carlo Lucchesi, Maud Toulmonde, Kevin Bourcier, François Le Loarer, Antoine Italiano
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	Cancer Communications
Online Access:	https://doi.org/10.1002/cac2.12268

Similar Items

Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis
by: Amandine Crombé, et al.
Published: (2024-06-01)

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas
by: Julie Blanchi, et al.
Published: (2023-09-01)

Targeting ERBB2 mutations in solid tumors: biological and clinical implications
by: Sophie Cousin, et al.
Published: (2018-06-01)

New strategies in soft tissue sarcoma treatment
by: Mariella Spalato-Ceruso, et al.
Published: (2024-09-01)

Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide
by: Maud Toulmonde, et al.
Published: (2024-02-01)

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study
by: Mariella Spalato-Ceruso, et al.
Published: (2022-10-01)

782-G The correlation of tumor immune microenvironment with response to neoadjuvant chemotherapy response in undifferentiated pleiomorphic sarcomas: an analysis of the NEOSARCOMICS study
by: Jean-Michel Coindre, et al.
Published: (2023-11-01)

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
by: Audrey Laroche, et al.
Published: (2017-04-01)

Local and Metastatic Relapse Features in Patients After a Primary Soft Tissue Sarcoma: Advocating for a Better-Tailored Follow-Up
by: Céline Blaye, et al.
Published: (2019-07-01)

Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas
by: Jean Philippe Guegan, et al.
Published: (2024-10-01)

Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study
by: Amandine Crombé, et al.
Published: (2024-01-01)

Intensity harmonization techniques influence radiomics features and radiomics-based predictions in sarcoma patients
by: Amandine Crombé, et al.
Published: (2020-09-01)

Prognostic impact of circulating tumor cells in patients with soft‐tissue sarcomas: a prospective study
by: Julie Blanchi, et al.
Published: (2023-03-01)

The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
by: Amandine Crombé, et al.
Published: (2022-12-01)

Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
by: Maud Toulmonde, et al.
Published: (2022-10-01)

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
by: Maud Toulmonde, et al.
Published: (2020-12-01)

Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study
by: Cheng-Ming Sun, et al.
Published: (2024-02-01)

IDO Targeting in Sarcoma: Biological and Clinical Implications
by: Imane Nafia, et al.
Published: (2020-03-01)

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
by: Antoine Italiano, et al.
Published: (2021-11-01)

Deep learning predicts patients outcome and mutations from digitized histology slides in gastrointestinal stromal tumor
by: Yu Fu, et al.
Published: (2023-07-01)

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications
by: M Spalato-Ceruso, et al.
Published: (2023-05-01)

Staging Systems and Nomograms for Soft Tissue Sarcoma
by: Maria Danieli, et al.
Published: (2023-03-01)

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
by: Matthieu Roulleaux Dugage, et al.
Published: (2021-12-01)

Clinical impact of extensive molecular profiling in advanced cancer patients
by: Sophie Cousin, et al.
Published: (2017-02-01)

Imaging Features of Alveolar Soft Part Sarcoma: Single Institution Experience and Literature Review
by: Paolo Spinnato, et al.
Published: (2023-11-01)

Development of a Nomogram to Predict the Outcome for Patients with Soft Tissue Sarcoma
by: Jonathan P. Bray, et al.
Published: (2023-03-01)

A novel nomogram and prognostic factor for metastatic soft tissue sarcoma survival
by: Dan Han, et al.
Published: (2024-05-01)

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison
by: Nicolas Penel, et al.
Published: (2023-08-01)

Targeting epigenetics in sarcomas through EZH2 inhibition
by: Antoine Italiano
Published: (2020-04-01)

Expression of Concern to: Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition
by: Benjamin Fourneaux, et al.
Published: (2019-11-01)

Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition
by: Benjamin Fourneaux, et al.
Published: (2019-01-01)

Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF)
by: Noémie Huchet, et al.
Published: (2024-01-01)

PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials
by: Antoine Italiano, et al.
Published: (2020-05-01)

Novel nomograms individually predict the survival of patients with soft tissue sarcomas after surgery
by: Zhang SL, et al.
Published: (2019-04-01)

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.
by: Lionel Perrier, et al.
Published: (2018-01-01)

Patterns of care and outcome of CIC‐rearranged sarcoma patients: A nationwide study of the French sarcoma group
by: Mehdi Brahmi, et al.
Published: (2023-04-01)

CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response
by: Laurys Boudin, et al.
Published: (2022-10-01)

Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors
by: Dario Callegaro, et al.
Published: (2019-12-01)

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
by: Jean-Yves Blay, et al.
Published: (2022-01-01)

New frontiers in the medical management of gastrointestinal stromal tumours
by: Alessandro Mazzocca, et al.
Published: (2019-05-01)